United States — Food and Drug Administration & Abbott Laboratories

Abbott Laboratories: Abbott Laboratories is mentioned in the context of a previous infant formula recall in 2022, which caused a national shortage, providing a comparison point for the current ByHeart recall.

Abbott Laboratories: Abbott Laboratories, through its Abbott Diabetes Care division, is at the center of this event due to the recall of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors. The malfunction has led to serious injuries and deaths, negatively impacting the company's reputation and potentially its stock price.